Power Probe PLC (AIM: PWR), a California-founded producer of automotive electrical diagnostic tools listed on AIM since December 2025, has announced that three of its products received industry awards in 2026 from two leading US automotive aftermarket publications. The recognised products span both its core electrical diagnostics range and the electric vehicle segment, reflecting the breadth of its portfolio. The recognition comes as the company continues to execute on the growth strategy outlined at its IPO, with a pipeline of further product launches planned for 2027.
Key Points
- Power Probe PLC (AIM: PWR) is a producer of automotive electrical diagnostic tools for professional service technicians, founded in 1992 in California, USA.
- Three products — PPFUSE Fuse Monitor, PPEVTEST EV Tester, and PPDRAW Draw Monitor — received separate industry awards in 2026 from Professional Tool & Equipment News and MOTOR magazine.
- The company designs and distributes over 130 products, with further launches planned for 2027; it listed on AIM in December 2025.
- Investors may be watching whether the award recognition translates into commercial momentum ahead of the 2027 product pipeline launches.
PPFUSE, PPEVTEST and PPDRAW Receive Awards from PTEN and MOTOR Magazine
The three recognised products each received distinct accolades. The PPFUSE Fuse Monitor won the 2026 PTEN Innovation Award in the Battery Starting & Charging category, selected by a panel of independent industry judges from Professional Tool & Equipment News. The PPEVTEST EV Tester received the 2026 PTEN People's Choice Award in the EV Tools & Equipment category, voted for directly by PTEN readers — the technicians who use such tools professionally. The PPDRAW Draw Monitor received a 2026 MOTOR Top 20 Award, run by MOTOR magazine to identify the most innovative products across the broader automotive industry during the year.
Awards Span Power Probe's Core Diagnostics and Growing Electric Vehicle Segment
The announcement states that the three awards collectively reflect the strength of Power Probe's product range across both its established electrical diagnostics market and the expanding electric vehicle tools segment. The company describes innovation as a core part of the growth strategy set out at the time of its IPO in December 2025. Power Probe currently designs and distributes over 130 products for professional service technicians, with the About section of the announcement noting the total portfolio extends to over 140 products. The company's mission statement is described as "Simplifying Automotive Diagnostics", a guiding principle since its founding in 1992.
CEO Chema Garcia Cites Innovation Strategy and 2027 Product Pipeline
Chief Executive Officer Chema Garcia commented in the announcement that receiving recognition from expert judges and technicians in a single year is "a great achievement" the company is "extremely proud of". Garcia noted that innovation has been central to the company's strategy and "a key driver of our strong growth since Power Probe was founded in 1992". He referenced continued investment in the product pipeline and plans to extend the company's reach, citing what the company sees as real opportunity to build on its current position. A pipeline of further product launches is planned for 2027, according to the announcement.
AIM-Listed PWR Operating in a Competitive US Automotive Aftermarket
Power Probe operates primarily in the US automotive aftermarket, serving professional service technicians through a design-and-distribute model. The company listed on AIM in December 2025 and competes in a sector where product innovation cycles and brand recognition among working technicians are key commercial drivers. The People's Choice Award, determined by technician votes rather than judges alone, may carry particular weight as a signal of end-user endorsement. Investors may be watching how the company translates its award recognition and planned 2027 product launches into revenue growth, though no financial figures were disclosed in this announcement.




Please wait processing your request...